Related Experiment Videos
Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors
G M London1, S J Marchais, A P Guerin
1Centre Hospitalier Manhes, Nephrology Division, Fleury Merogis, France.
Insights
Left ventricular hypertrophy is common in end-stage renal disease due to fluid overload and stiff arteries. This condition worsens over time, impacting heart function in patients undergoing hemodialysis.
Area of Science:
- Cardiology
- Nephrology
- Cardiovascular Medicine
Background:
- Left ventricular (LV) hypertrophy is a prevalent cardiovascular complication in patients with end-stage renal disease (ESRD).
- It arises from combined chronic volume and pressure overload, presenting mixed concentric and eccentric features.
- Contributing factors include arteriovenous (AV) shunts, fluid overload, anemia, and increased arterial stiffness.
Purpose of the Study:
- To investigate the characteristics and progression of left ventricular hypertrophy in ESRD patients.
- To understand the underlying causes of LV hypertrophy in this population.
- To assess the impact of hemodialysis on cardiac function over time.
Main Methods:
- Observational study design.
- Analysis of cardiovascular alterations in ESRD patients.
- Assessment of ventricular function and arterial properties.
Main Results:
- LV hypertrophy is the most common cardiac alteration in ESRD patients.
- Chronic flow overload (AV shunt, fluid overload, anemia) and pressure overload (arterial stiffness) drive hypertrophy.
- Initially preserved systolic function deteriorates, alongside impaired diastolic filling and worsening function over time with hemodialysis.
Conclusions:
- Left ventricular hypertrophy is a progressive and significant complication in ESRD patients.
- Hemodialysis treatment is associated with the worsening of cardiac function in these patients.
- Management strategies should address fluid balance, anemia, and arterial stiffness to mitigate cardiac remodeling.
Abstract:
Left ventricular (LV) hypertrophy is the most common cardiovascular alteration observed in end-stage renal disease patients. LV hypertrophy results from chronic flow and pressure overload and combines features of concentric and eccentric hypertrophy. The causes of chronic flow overload are the presence of AV shunt, salt and water overload, and anemia. The pressure overload is related to alterations of physical properties of large arteries characterized by an increased arterial and aortic stiffness. The systolic function of hypertrophied ventricle is preserved, but the diastolic filling is impaired. The ventricular hypertrophy progresses over the time on hemodialysis together with a progressive worsening of both systolic and diastolic functions.